photo of Wei Shern Lee

Wei Shern Lee

Wei Shern Lee

Details

Role Honorary Fellow
Research area Bruce Lefroy Centre
Wei Shern Lee is an Honorary Fellow at the Neurogenetic Research Group led by Prof. Paul Lockhart. After finishing his PhD in 2021, Wei was awarded the MCRI Early Career Research Fellowship to continue his research on understanding the genetic basis and pathogenic mechanism of developmental brain malformations, which are a significant cause of drug-resistant focal epilepsy.

Wei has a strong interest in the application of genomic technologies to improve disease diagnosis and understand disease mechanisms. His research at MCRI focused on the investigation of epileptic brain tissue using deep sequencing approaches and single cell technologies. The ultimate goals are twofold: 1. To progress basic science and the understanding of brain development, and 2. To facilitate the development of novel therapeutic approaches tailored to the specific genetic fault underlying each patient’s condition.
Wei Shern Lee is an Honorary Fellow at the Neurogenetic Research Group led by Prof. Paul Lockhart. After finishing his PhD in 2021, Wei was awarded the MCRI Early Career Research Fellowship to continue his research on understanding the genetic basis...
Wei Shern Lee is an Honorary Fellow at the Neurogenetic Research Group led by Prof. Paul Lockhart. After finishing his PhD in 2021, Wei was awarded the MCRI Early Career Research Fellowship to continue his research on understanding the genetic basis and pathogenic mechanism of developmental brain malformations, which are a significant cause of drug-resistant focal epilepsy.

Wei has a strong interest in the application of genomic technologies to improve disease diagnosis and understand disease mechanisms. His research at MCRI focused on the investigation of epileptic brain tissue using deep sequencing approaches and single cell technologies. The ultimate goals are twofold: 1. To progress basic science and the understanding of brain development, and 2. To facilitate the development of novel therapeutic approaches tailored to the specific genetic fault underlying each patient’s condition.

Top Publications

  • Lee, WS, Stephenson, SEM, Pope, K, Gillies, G, Maixner, W, Macdonald-Laurs, E, MacGregor, D, D'Arcy, C, Jackson, G, Harvey, AS, et al. Genetic characterization identifies bottom-of-sulcus dysplasia as an mTORopathy.. Neurology 95(18) : e2542 -e2551 2020
    view publication
  • Stephenson, SE, Owens, HG, Richards, KL, Lee, WS, D’Arcy, C, Barton, S, Mandelstam, SA, Maixner, WJ, MacGregor, D, Petrou, S, et al. Dysmorphic neuron density underlies intrinsic epileptogenicity of the centre of cortical tubers. 621607 2024
    view publication
  • Lee, WS, Baldassari, S, Stephenson, SEM, Lockhart, PJ, Baulac, S, Leventer, RJ. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis. International Journal of Molecular Sciences 23(3) : 1344 2024
    view publication
  • Macdonald-Laurs, E, Warren, AEL, Francis, P, Mandelstam, SA, Lee, WS, Coleman, M, Stephenson, SEM, Barton, S, D'Arcy, C, Lockhart, PJ, et al. The clinical, imaging, pathological and genetic landscape of bottom-of-sulcus dysplasia. Brain awad379 2023
    view publication
  • Lee, WS, Lockhart, PJ. Utility of droplet digital polymerase chain reaction for studying somatic mosaicism: brain malformations and beyond. Neural Regeneration Research 18(11) : 2389 -2390 2023
    view publication

Page 1 of 3

Career information